Lázaro JL - Search Results

1

Early use of tacrolimus as rescue therapy for refractory liver allograft rejection.

Charco R, Murio E, Edo A, Balsells J, Lázaro JL, Bilbao I, Hidalgo E, Margarit C. Charco R, et al. Among authors: lazaro jl. Transpl Int. 1998;11 Suppl 1:S313-7. doi: 10.1007/s001470050486. Transpl Int. 1998. PMID: 9665004 Clinical Trial.

2

Immunosuppression based on everolimus in liver transplant recipients with severe early post-transplantation neurotoxicity.

Bilbao I, Dopazo C, Castells L, Lazaro J, Caralt M, Sapisochin G, Charco R. Bilbao I, et al. Transplant Proc. 2014 Nov;46(9):3104-7. doi: 10.1016/j.transproceed.2014.10.001. Transplant Proc. 2014. PMID: 25420835

3

Liver transplantation in HIV-HCV coinfected patients: a case-control study.

Castells L, Escartín A, Bilbao I, Len O, Allende H, Vargas V, Ribera E, Lázaro JL, Bueno J, Balsells J, Esteban R, Pahissa A, Margarit C. Castells L, et al. Among authors: lazaro jl. Transplantation. 2007 Feb 15;83(3):354-8. doi: 10.1097/01.tp.0000251378.70853.90. Transplantation. 2007. PMID: 17297413

4

Compassionate use of FK 506 in liver transplantation.

Murio JE, Balsells J, Lázaro JL, Charco R, Margarit C. Murio JE, et al. Among authors: lazaro jl. Transplant Proc. 1995 Aug;27(4):2336. Transplant Proc. 1995. PMID: 7544501 No abstract available.

5

Experience in therapy of chronic liver allograft rejection.

Charco R, Ruiz C, Allende E, Balsells J, Lazaro JL, Murio E, Bilbao I, Gifre E, Margarit C. Charco R, et al. Among authors: lazaro jl. Transplant Proc. 1995 Aug;27(4):2293-4. Transplant Proc. 1995. PMID: 7652811 No abstract available.

6

Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation.

Charco R, Vargas V, Balsells J, Lázaro JL, Murio E, Jaurrieta E, Martorell J, Margarit C. Charco R, et al. Among authors: lazaro jl. J Hepatol. 1996 Apr;24(4):452-9. doi: 10.1016/s0168-8278(96)80166-8. J Hepatol. 1996. PMID: 8738732

7

Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection?

Charco R, Vargas V, Allende H, Edo A, Balsells J, Murio E, Lázaro JL, Bilbao I, Margarit C. Charco R, et al. Among authors: lazaro jl. Transpl Int. 1996;9 Suppl 1:S195-7. doi: 10.1007/978-3-662-00818-8_49. Transpl Int. 1996. PMID: 8959825

8

Risk factors for severe ischemic injury after liver transplantation.

Bilbao I, Charco R, Hidalgo E, Lázaro JL, Balsells J, Murio E, Margarit C. Bilbao I, et al. Among authors: lazaro jl. Transplant Proc. 1997 Feb-Mar;29(1-2):368-70. doi: 10.1016/s0041-1345(96)00123-6. Transplant Proc. 1997. PMID: 9123041 No abstract available.

9

Relevance of positive lymphocytotoxic crossmatch and immunosuppressive regimens in the outcome of liver transplants.

Charco R, Vargas V, Balsells J, Lázaro JL, Murio E, Jaurrieta E, Martorell J, Margarit C. Charco R, et al. Among authors: lazaro jl. Transplant Proc. 1997 Feb-Mar;29(1-2):461-2. doi: 10.1016/s0041-1345(96)00202-3. Transplant Proc. 1997. PMID: 9123082 No abstract available.

10

Risk factors for acute renal failure requiring dialysis after liver transplantation.

Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, Murio E, Margarit C. Bilbao I, et al. Among authors: lazaro jl. Clin Transplant. 1998 Apr;12(2):123-9. Clin Transplant. 1998. PMID: 9575400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters